Short answer
As of October 2026, yes, once certified and only where licensed. Google's US healthcare rules have no exception for ads shown only to prescribers: a pharmacy that fills by mail needs LegitScript or NABP accreditation plus Google certification, and targeting locations where it isn't licensed is not allowed. On Meta, naming a prescription drug needs LegitScript and Meta's authorization. MedScale Health, a paid acquisition agency for telehealth brands and clinics, builds B2B pharmacy campaigns on Google and Meta.
What this means for you
- Google's US healthcare rules have no exception for ads shown only to prescribers. The one healthcare-professional exception on Google's page sits under Japan.
- A pharmacy that fills by mail or remote ordering counts as an online pharmacy for Google, and needs LegitScript or NABP accreditation plus Google certification before its ads serve.
- Target only the states where the pharmacy is licensed. Google treats targeting locations where you aren't licensed as an egregious violation.
- On Meta, naming a prescription drug needs active LegitScript certification and Meta's authorization.
- Disclose every domain you operate to LegitScript, sister sites included, and keep FDA's compounding claim limits on all of them.
MedScale Health, a paid acquisition agency for telehealth brands and clinics, runs Google and Meta campaigns for 503A pharmacies that sell to telehealth companies and prescribers. This page sets out the platform and FDA rules that apply when the audience is prescribers rather than patients. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.
No prescriber-only carve-out on Google
Google's Healthcare and medicines policy restricts the promotion of services related to the online prescribing, dispensing and sale of prescription drugs, and names online pharmacies among the businesses in scope. Its US section allows online pharmacies accredited through LegitScript's Internet pharmacy certification, which Google describes as available to websites that accept refills, transfers or new prescriptions, or to pharmacies that fill via mail-order or another remote ordering service, or through NABP's Digital Pharmacy Accreditation or .Pharmacy programs. Advertisers must also be certified with Google.
A campaign aimed at doctors is not exempt. Google's page has one exception for websites accessible only to healthcare professionals, and it sits in the Japan section, where it lets such sites use prescription drug terms in keywords. The US section has no equivalent. Google also says it errs on the side of caution with landing pages that appear to facilitate the online sale or dispensing of medicines, and that in judging pharmacy violations it may review your ad, website, accounts and third-party sources.
Licensed states and Google's targeting rule
Google's Unauthorized pharmacies policy says offering prescription drugs without a prescription is not allowed and targeting locations where you aren't licensed is not allowed. Google treats violations as egregious: accounts are suspended upon detection and without prior warning, and reinstated only in compelling circumstances. Build the location list from active licenses only. Pending applications don't count, and a license limited in scope should be cleared with counsel before its state goes in. Drug names follow the Restricted drug terms policy: in the US they can appear in ads and landing pages without certification, but keyword-targeting them requires it.
Meta for pharmacies
Meta's prescription drug rules require online pharmacies to be actively certified with LegitScript before applying for authorization, and authorized advertisers may promote prescription drugs only to people 18 and over in the US, Canada or New Zealand, in the countries where they are certified. Meta's exemption covers ads that promote telehealth services generally and says nothing about pharmacy services, so an ad that names a compounded drug needs certification and authorization. Write the ad for the prescriber: turnaround, states served, how prescriptions are sent and how patients receive them.
Microsoft and LinkedIn, for completeness
Microsoft Advertising requires online pharmacies to be preapproved, and its US rules say online pharmacies advertising prescription drugs must be accredited by NABP or LegitScript. It also requires compounded weight loss drugs to be labeled with "This is a compounded drug" or an equivalent disclaimer. LinkedIn's advertising policies say ads promoting pharmacy and telehealth services are restricted, require prior authorization, may only run in the United States and must not target members under 18. MedScale runs Google and Meta; these rules are listed so the picture is complete.
LegitScript: every domain, every affiliate
LegitScript lists compounding pharmacies and mail-order pharmacies among businesses eligible for Healthcare Certification. Its standards require applicants to be licensed in the jurisdictions they serve, including where the patient is located, to provide all domain names and websites under their control, and to disclose all affiliates. Its pricing section says all operated domains must be disclosed, even though you choose which to certify. A sister site with unsupported claims is part of the review, because LegitScript's transparency standard covers claims of benefits not supported by a regulatory body such as the FTC or FDA.
FDA limits on compounding claims
FDA's chart of FD&C Act provisions says section 503A compounding must be based on a valid prescription for an identified individual patient; it can happen after the prescription arrives, or in limited quantities before it. Copy should describe filling patient-specific prescriptions, not supplying stock. Drugs compounded under 503A are exempt from premarket approval, which is why they are not FDA-approved.
FDA's reminders to telehealth companies promoting compounded drugs list as misleading: calling a compounded drug a generic or the same as an approved drug, claiming FDA approval, and claiming it comes from an FDA-approved or FDA-licensed pharmacy, because FDA does not approve or license any facility. Ingredients matter too. FDA keeps a list of bulk drug substances that may present significant safety risks, current as of April 22, 2026, and it is worth checking before any ingredient appears in an ad or on a sister site.
What MedScale does
MedScale Health builds prescriber-facing Google and Meta campaigns for 503A pharmacies once certification is in place, limits location targeting to active licenses, writes copy within FDA's compounding claim limits, and checks every domain the pharmacy operates before launch. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. No volume of new prescribers is promised. Book the free growth audit at medscale.health/audit for a written plan.
Common questions
- 01Do B2B pharmacy Google Ads need certification?
- Yes, in the US. Google's healthcare policy has no exception for ads shown only to prescribers; a pharmacy that fills by mail or remote ordering needs LegitScript or NABP accreditation and Google certification before its ads serve.
- 02Can a compounding pharmacy target states where its license is pending?
- No. Google's Unauthorized pharmacies policy says targeting locations where you aren't licensed is not allowed, and treats violations as egregious, with suspension on detection and without prior warning. Use active licenses only.
- 03Does LegitScript need to know about a pharmacy's other websites?
- Yes. LegitScript requires applicants to provide all domain names and websites under their control and to disclose all affiliates. You choose which domains to certify, but every operated domain must be disclosed.
- 04Can a 503A pharmacy call itself FDA-approved?
- No. FDA says it does not approve or license any pharmacy or outsourcing facility, and compounded drugs are not FDA-approved. Claims of FDA approval or FDA licensing are among the misleading claims FDA lists for compounded drug promotion.
Sources
- 01Google Ads policy: Healthcare and medicines (United States section)checked October 8, 2026
- 02Google Ads policy: Prescription drug serviceschecked October 8, 2026
- 03Google Ads policy: Restricted drug termschecked October 8, 2026
- 04Meta Advertising Standards: Drugs and Pharmaceuticalschecked October 8, 2026
- 05Meta Business Help Center: About Meta's Prescription Drugs advertising policychecked October 8, 2026
- 06Microsoft Advertising policy: Healthcare and Pharmaceutical (updated Oct 5, 2026)checked October 8, 2026
- 07LinkedIn Advertising Policieschecked October 8, 2026
- 08LegitScript: Healthcare Certification (standards and multiple websites)checked October 8, 2026
- 09LegitScript: Healthcare Certification FAQschecked October 8, 2026
- 10FDA: FD&C Act provisions that apply to human drug compoundingchecked October 8, 2026
- 11FDA: What telehealth companies should know when promoting compounded drugschecked October 8, 2026
- 12FDA: Bulk drug substances for compounding that may present significant safety riskschecked October 8, 2026
Related answers
Does a Compounding Pharmacy Need LegitScript Certification?
As of October 2026, yes if the pharmacy sells, dispenses or facilitates prescription medications online or card-not-present: LegitScript's Healthcare Merchant Certification explicitly covers pharmacies including sterile compounding, and LegitScript calls the certification a necessary part of approval for card-not-present Visa and Mastercard transactions and for advertising on Google and Bing. MedScale Health, a paid acquisition agency for telehealth brands and clinics, sees compounding pharmacies fail on one thing above all: marketing a compounded GLP-1 as if it were the FDA-approved product.
Reviewed October 5, 2026
What Are the Rules for Advertising an Online Pharmacy?
As of October 2026, a US online pharmacy needs third-party certification before it advertises on Google, Meta, Microsoft or TikTok: LegitScript or NABP for Google, Microsoft and TikTok, and LegitScript only for Meta, then each platform's own approval. On TikTok, ads for prescription medicine also need proof of FDA approval. MedScale Health, a paid acquisition agency for telehealth brands and clinics, helps telehealth brands and their pharmacy partners through certification and launch.
Reviewed October 8, 2026
Can You Advertise BPC-157, and What Does the FDA Status Mean?
As of October 2026, BPC-157 is not FDA-approved and cannot be advertised as a product on Google or Meta. FDA's bulk substances page, current April 22, 2026, lists it as nominated but withdrawn from Category 2, and FDA's compounding advisory committee voted 8 to 6 in July 2026 to recommend it for the 503A bulks list; the vote is non-binding and we found no FDA action. MedScale, a paid acquisition agency for telehealth brands and clinics, runs the consult for peptide clinics, never the compound.
Reviewed October 5, 2026
What Are the Rules for Advertising Compounded Semaglutide in 2026?
As of October 2026, compounded semaglutide can be advertised only on much narrower ground than during the shortage. FDA resolved the semaglutide shortage on February 21, 2025, enforcement discretion ended in April and May 2025, and FDA's June 15, 2026 guidance tells telehealth companies not to present compounded drugs as generic, equivalent or FDA-approved. MedScale, a paid acquisition agency for telehealth brands and clinics, rewrites claims built on the shortage-era footing. Compounded semaglutide is compounded, not FDA-approved.
Reviewed October 5, 2026
Last reviewed October 8, 2026. Platform policies change often; we re-verify every answer quarterly.